Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY: DNA )

14.73 +1.18 (+8.71%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
40 Biggest Movers From Yesterday
Gainers Volcon, Inc. (NASDAQ: VLCN) shares jumped 97.5% to settle at $10.86 on Wednesday as the company priced its IPO at $5.50 per share. Voyager Therapeutics, Inc. (NASDAQ:... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Cathie Wood Sells $49.4M In Tesla And Buys $87.5M In Ginkgo Bioworks On Dip As Stock Becomes Target Of Short Sellers
Cathie Wood-led Ark Invest on Wednesday snapped up shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the day the synthetic biology company stock was hit hard by two back-to-... 
Via Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors
From Cruz The Law Offices of Frank R. Cruz
Via Business Wire
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
GINKGO BIOWORKS INVESTOR ALERT - Investors Who Have Suffered Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.
PHILADELPHIA, PA / ACCESSWIRE / October 6, 2021 / Kehoe Law Firm, P.C. is investigating whether Ginkgo Bioworks ("Ginkgo" or the "Company") (NYSE:DNA) violated federal securities laws. Ginkgo investors... 
From Kehoe Law Firm, P.C.
Via AccessWire
Topics Fraud
Exposures Legal
DNA Stock: 7 Things to Know About the Short Report Hammering Ginkgo Bioworks
Today, Ginko Bioworks and DNA stock are firmly in the sights of short-sellers as various claims are made about an elaborate fraud underway. 
Via InvestorPlace
Topics Fraud
Exposures Legal
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Ginkgo Bioworks Stock Drops 20% After Short Sellers Call Company A 'Colossal Scam'
Shares of synthetic biology company Ginkgo Bioworks Holdings Inc (NYSE: 
Via Benzinga
26 Stocks Moving In Wednesday's Mid-Day Session
Gainers Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares jumped 54.1% to $3.8050 after the company announced licensing option agreement with Pfizer for capsids generated from... 
Via Benzinga
Here's Why This Cathie Wood Stock Is Crashing Today
Scorpion Capital is shooting some venom at a new target today. 
Via The Motley Fool
DNA INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Ginkgo Bioworks Holdings, Inc. Investors with Losses to Inquire About Class Action Investigation – DNA
From Rosen Law Firm
Via Business Wire
Mid-Morning Market Update: Markets Open Lower; Acuity Brands Posts Upbeat Q4 Results
Following the market opening Wednesday, the Dow traded down 1.12% to 33,929.34 while the NASDAQ fell 0.69% to 14,334.78. The S&P also fell, dropping 0.90% to 4,306.41. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
Here's an Up-and-Coming Biotech Stock to Watch With a Cannabis Connection
And it has a really great ticker that many other biotechs might envy. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Why Shares of Ginkgo Bioworks Are Rising Today
A new analyst rating has investors excited. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2021
Upgrades For Methanex Corp (NASDAQ: 
Via Benzinga
DNA Stock Cooks Up 10% Gains on Ginkgo Biowork’s First Trading Day
Ginkgo Bioworks knows about growth and so far, it seems as though DNA stock does as well as it kicks off under an aptly titled ticker. 
Via InvestorPlace
SRNG, DNA: 14 Things to Know About Ginkgo Bioworks and the Soaring Eagle SPAC Merger
Ginkgo Bioworks (DNA) stock is set to start trading today as the company completes its merger with SPAC Soaring Eagle (SRNG). 
Via InvestorPlace
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.